Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controversies surrounding xanthine therapy.

David Millar1, Barbara Schmidt

  • 1Department of Paediatrics, McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5.

Seminars in Neonatology : SN
|March 31, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective economic evaluation ancillary to a trial of higher versus lower hemoglobin transfusion thresholds for preterm infants.

Neonatology·2026
Same author

Hypnotic safety suggestions reduce cortisol awakening response and morning heart rate in daily life.

Scientific reports·2026
Same author

Limited Diagnostic Utility of C-reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR) for Ventriculitis in Adult and Pediatric Traumatic Brain Injury Patients With External Ventricular Drains: A Retrospective Cohort Study.

Cureus·2026
Same author

Prediction of anxiety in children aged 7-12 during preoperative anaesthesia evaluation - a prospective observational study.

Perioperative medicine (London, England)·2026
Same author

SARS-CoV-2 evolution enhances endocytic uptake while preserving TMPRSS2-dependent fusion.

Frontiers in immunology·2026
Same author

Hypnosis and affective neuroscience.

International review of neurobiology·2025

Methylxanthines like caffeine treat infant apnea but may pose risks. Ongoing trials assess the long-term safety and efficacy of these common neonatal drugs.

Area of Science:

  • Neonatal Medicine
  • Pharmacology
  • Neuroscience

Background:

  • Methylxanthines (aminophylline, theophylline, caffeine) are widely used for treating apnea of prematurity in newborns.
  • These drugs function as adenosine receptor antagonists, reducing respiratory pauses and mechanical ventilation needs.

Purpose of the Study:

  • To evaluate the safety and efficacy of methylxanthine therapy in very preterm infants.
  • To address growing concerns regarding potential adverse effects of methylxanthines in neonatal care.

Main Methods:

  • A review of existing research on methylxanthine actions and potential side effects.
  • An ongoing international controlled clinical trial investigating long-term outcomes in very low birth weight infants.

Main Results:

Related Experiment Videos

  • Methylxanthines are effective in managing apnea of prematurity.
  • Emerging research suggests potential adverse effects, including impaired growth, reduced neuroprotection, and abnormal behavior.

Conclusions:

  • While established for apnea treatment, methylxanthine therapy requires careful consideration due to potential risks in vulnerable preterm infants.
  • Further research and clinical trials are crucial to fully understand the long-term safety profile of methylxanthines in neonatal medicine.